ValiRx plc (AIM:VAL)
London · Delayed Price · Currency is GBP · Price in GBX 0.1300
+0.0050 (4.00%)
Sep 25, 2026, 3:40 PM GMT
ValiRx Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.03 | 0.03 | 0.05 | 0.01 | - | - | |
Revenue Growth | -34.36% | -36.97% | 418.49% | - | - | - |
Cost of Revenue | 0.04 | 0.04 | 0.06 | 0 | - | - |
Gross Profit | -0 | -0.01 | -0.01 | 0.01 | - | - |
Selling, General & Admin | 1.51 | 1.59 | 1.91 | 1.89 | 1.5 | 1.22 |
Research & Development | 0.2 | 0.23 | 0.25 | 0.38 | 0.55 | 0.3 |
Other Operating Expenses | - | - | -0.03 | - | - | -0.03 |
Operating Expenses | 1.7 | 1.82 | 2.13 | 2.31 | 2.59 | 1.68 |
Operating Income | -1.71 | -1.82 | -2.14 | -2.3 | -2.59 | -1.68 |
Interest Expense | -0.01 | -0 | -0 | -0 | -0.01 | -0 |
Interest & Investment Income | 0.01 | 0.01 | 0.01 | - | - | - |
EBT Excluding Unusual Items | -1.71 | -1.82 | -2.13 | -2.3 | -2.6 | -1.68 |
Impairment of Goodwill | -0.6 | -0.6 | - | - | - | - |
Pretax Income | -2.31 | -2.42 | -2.13 | -2.3 | -2.6 | -1.68 |
Income Tax Expense | -0.13 | -0.13 | -0.13 | -0.18 | -0.19 | -0.13 |
Earnings From Continuing Operations | -2.19 | -2.29 | -2 | -2.13 | -2.41 | -1.55 |
Net Income to Company | -2.19 | -2.29 | -2 | -2.13 | -2.41 | -1.55 |
Minority Interest in Earnings | 0.05 | 0.06 | 0.09 | 0.09 | 0.04 | 0.03 |
Net Income | -2.14 | -2.23 | -1.92 | -2.04 | -2.37 | -1.52 |
Net Income to Common | -2.14 | -2.23 | -1.92 | -2.04 | -2.37 | -1.52 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 646 | 414 | 132 | 102 | 77 | 65 |
Shares Outstanding (Diluted) | 646 | 414 | 132 | 102 | 77 | 65 |
Shares Change | 154.82% | 213.81% | 29.74% | 31.39% | 18.92% | 71.53% |
EPS (Basic) | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 |
EPS (Diluted) | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.36 | -1.52 | -1.62 | -2.06 | -1.71 | -1.26 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.02 |
Gross Margin | -15.15% | -19.92% | -26.31% | 85.00% | - | - |
Operating Margin | -5233.68% | -5809.21% | -4302.70% | -23943.12% | - | - |
Profit Margin | -6547.86% | -7115.13% | -3848.71% | -21226.05% | - | - |
Free Cash Flow Margin | -4161.01% | -4856.94% | -3260.70% | -21495.13% | - | - |
EBITDA | -1.49 | -1.59 | -1.87 | -2.05 | -2.39 | -1.46 |
D&A For EBITDA | 0.22 | 0.24 | 0.27 | 0.25 | 0.2 | 0.22 |
EBIT | -1.71 | -1.82 | -2.14 | -2.3 | -2.59 | -1.68 |